You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

122 Results
Guidelines and Advice
Status: Current
ID: 5-9
Version: 2
Jan 2020
Guidelines and Advice
Status: Current
ID: GL #4-4v2
Version: 2
Sep 2020
Guidelines and Advice
Status: Archived
ID: 5-6c
Nov 2000
Statistical Reports
Oct 2020
Guidelines and Advice
Status: In-Review
ID: GL END 7-3
Version: 4
Apr 2020
Drug
Other Name(s): Vepesid®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jul 2020
Drug
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jul 2020
Drug
Other Name(s): Zinecard®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2020
Drug
Other Name(s): Procytox®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Oct 2020
Regimen
Cancer Type:
Sarcoma, 
Soft Tissue, 
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
dacarbazine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2020
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
DACTINomycin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2020
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    exemestane
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
exemestane
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2020

Pages